Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Woodside Energy
WDS
$43.2B
| $2.42M | ﹤0.01% |
167,110
+16,340
| +11% | +$249K |
|
2552
Qiagen
QGEN
$8.61B
| $2.41M | ﹤0.01% |
60,091
-119,737
| -67% | -$5.04M |
|
2553
3D Systems Corp
DDD
$588M
| $2.41M | ﹤0.01% |
1,136,177
-56,930
| -5% | -$193K |
|
2554
Pulse Biosciences
PLSE
$2.65B
| $2.41M | ﹤0.01% |
149,639
+433
| +0.3% | +$8.07K |
|
|
KLC
2555
KinderCare Learning Companies
KLC
$605M
| $2.4M | ﹤0.01% |
207,040
-554
| -0.3% | -$10.3K |
|
2556
Heron Therapeutics
HRTX
$94.5M
| $2.4M | ﹤0.01% |
1,089,449
-16,354
| -1% | -$31.7K |
|
|
LPRO
2557
DELISTED
Open Lending Corp
LPRO
| $2.36M | ﹤0.01% |
855,481
+103,084
| +14% | +$512K |
|
2558
Celcuity
CELC
$4.55B
| $2.35M | ﹤0.01% |
232,036
-5,670
| -2% | -$64.1K |
|
2559
SGHC Ltd
SGHC
$6.6B
| $2.34M | ﹤0.01% |
362,798
| – | – |
|
2560
Xeris Biopharma Holdings
XERS
$1.27B
| $2.33M | ﹤0.01% |
423,775
+20,903
| +5% | +$84.4K |
|
2561
HBT Financial
HBT
$1.32B
| $2.3M | ﹤0.01% |
102,833
-2,520
| -2% | -$59.3K |
|
2562
Microvision
MVIS
$76.1M
| $2.3M | ﹤0.01% |
123,635
+1,497
| +1% | +$31.3K |
|
2563
Senseonics Holdings Inc
SENS
$269M
| $2.3M | ﹤0.01% |
175,116
+8,131
| +5% | +$134K |
|
2564
Butterfly Network
BFLY
$2.21B
| $2.29M | ﹤0.01% |
1,003,940
+68,110
| +7% | +$244K |
|
2565
GoodRx Holdings
GDRX
$1.26B
| $2.29M | ﹤0.01% |
518,941
-19,647
| -4% | -$92.2K |
|
2566
Designer Brands
DBI
$336M
| $2.28M | ﹤0.01% |
624,876
+73,736
| +13% | +$347K |
|
2567
Oric Pharmaceuticals
ORIC
$1.34B
| $2.28M | ﹤0.01% |
408,505
-9,450
| -2% | -$82.6K |
|
|
FSUN
2568
FirstSun Capital Bancorp
FSUN
$1.96B
| $2.28M | ﹤0.01% |
62,954
-3,690
| -6% | -$147K |
|
2569
Fox Class B
FOX
$23.2B
| $2.27M | ﹤0.01% |
43,126
+5,089
| +13% | +$253K |
|
2570
Legacy Housing
LEGH
$687M
| $2.27M | ﹤0.01% |
90,112
-550
| -0.6% | -$14K |
|
2571
HighPeak Energy
HPK
$867M
| $2.26M | ﹤0.01% |
178,679
-5,040
| -3% | -$67.7K |
|
2572
Melco Resorts & Entertainment
MLCO
$2.14B
| $2.26M | ﹤0.01% |
429,131
+75,935
| +21% | +$428K |
|
2573
Anika Therapeutics
ANIK
$270M
| $2.25M | ﹤0.01% |
149,935
+12,473
| +9% | +$207K |
|
2574
Ardagh Metal Packaging
AMBP
$3B
| $2.25M | ﹤0.01% |
745,986
+342,002
| +85% | +$960K |
|
2575
Algoma Steel
ASTL
$419M
| $2.25M | ﹤0.01% |
415,143
+3,643
| +0.9% | +$27.4K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.